Alberto Pascual
Alberto Pascual is currently the Product Portfolio Leader for Signals Workflows at Revvity Signals, where he drives the end-to-end workflow strategy for the Signals platform, helping turn complex scientific data into actionable insights. He holds a PhD in Bioinformatics and brings extensive experience in Data Science across the Biomedical and Biopharma domains. He earned a degree in Computer Science and completed his doctorate at the Autonomous University of Madrid. Following a postdoctoral period, he joined the National Center for Biotechnology (CNB), where he led a Bioinformatics Research and Core Facility group.
In 2003, he co-founded Integromics, a pioneering bioinformatics startup that was later acquired by PerkinElmer in 2014. At PerkinElmer, he served as Senior Manager of AI and Analytics Innovation.
In 2020, he joined the Danaher Life Sciences group as Director of Data Science and Analytics at IDBS, where he led the development and execution of AI, data science, and analytics strategies focused on applications in drug discovery, development, clinical research, and diagnostics. In 2024, Alberto returned to Revvity Signals to lead the AI driven workflow solutions.